CREATOR OF LINDY SKIN
DISCUSSES
SKINCARE FOR LIFE:
HELPING YOU WIN BACK A LITTLE CONTROL OF YOUR (LIFE) EVERY DAY
First And Only Complete Skin Care Line Developed For The Unique Needs Of People Undergoing Cancer Treatment www.lindiskin.com
Lindi Skin, Northwestern University And CancerCare Release Results Of Study
For Lindy Snider, the creation of
Lindi Skin started with her personal experience watching friends go through cancer treatment. They expected the nausea, fatigue and hair loss associated with chemotherapy and radiation therapy, but they were not aware of the impact that these therapies would have on their skin. In discovering there was not one line of skin care products specifically developed for people with cancer, it occurred to Lindi that someone had to create one.. and so she did. She aligned herself with dermatologists, oncologists, nurses, patients and skincare formulators to create the first and only complete skin care line developed for the unique needs of people with cancer.
A recent survey by CancerCare showed that nearly 80% of people with cancer were concerned about the impact skin effects had on their quality of life during treatment. Unfortunately, many people don’t realize the issues created by skin effects. In a first-ever initiative, renowned health-care providers identify and describe how cancer treatment-related toxicities have a negative effect on quality of life from the perspective of patients and survivors.
Results of the new study according to Dr. Mario Lacouture, Associate Attending Physician, Memorial Sloan-Kettering Cancer Center, the impact of dermatologic toxicities was found to be unanticipated prior to cancer treatments, to a greater degree than gastrointestinal and constitutional side effects stated Since these events have a negative effect on survivors’ lives, pretreatment counseling and effective interventions are vital in order to maximize quality of life and minimize unnecessary treatment interruptions or discontinuations.
This landmark skincare Study made Possible by CancerCare and Lindi Skin was pursued by medical leaders and centers including: Mona Gandhi, Department of Dermatology, Northwestern Universitys Feinberg School of Medicine; Karen Oishi, University of Texas, M.D. Anderson Cancer Center, Houston, TX; Beth Zubal, Washington University School of Medicine, St. Louis, MO; and Dr, Mario E. Lacouture SERIES Clinic, Robert H Lurie Comprehensive Cancer Center, Northwestern Universitys Feinberg School of Medicine, now at Memorial Sloan-Kettering Cancer Center.
Advances in cancer treatments have greatly improved survival rates for many diagnoses. Yet, the lingering side effects of many cancer treatments have only recently begun to be addressed, said Rosalie Canosa, Program Division Director, CancerCare. This survey breaks new ground in understanding not only the physical but also the psychological impact of these side effects from the patients perspective, and what can be done to help alleviate them.
